A case in which the Court determined that insurance companies could potentially provide contraceptive coverage to employees of organizations that object to such coverage on religious grounds without the organizations needing to provide notification.

A case in which the Court determined that the judgment bar of the Federal Tort Claims Act (FTCA) does not apply to claims dismissed for falling under the exceptions to the FTCA.

A case in which the Court determined that Chapter 9 of the Bankruptcy Code preempted the Puerto Rico statute that allowed public utilities to restructure their debt.

A case in which the Court held that some sections of the Racketeer Influenced Corrupt Organizations (RICO) statute can apply extraterritorially because Congress clearly based them on predicate offenses that can occur outside of the United States.

A case in which the Court determined that members of Congress whose chances of reelection might be impaired by a new districting plan did not have standing under Article III of the U.S. Constitution to appeal their case to the Supreme Court.

A case in which the Court determined that the regulations at issue unconstitutionally imposed an undue burden on women seeking abortions because they created a substantial burden and did not actually serve the stated government interest.

A case in which the Court determined that the “actual fraud” language of the bankruptcy statute encompasses traditional forms of fraud and is not limited to fraudulent representation.

A case in which the Court determined that the Sexual Offender Registration and Notification Act does not require a sex offender who is moving to a country outside of U.S. jurisdiction to update his residence with the sexual offender registry.

A case in which the Court held that the Nevada law requiring elected officials to disqualify themselves when they are asked to vote on matters that present a conflict of interest was constitutional.

A case in which the Court held that a Vermont statute banning the sale, transmission or use of prescription drug user data violated protected speech of the pharmaceutical research companies, manufacturers and others who use that data.